Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 21 | 2023 | 1965 | 1.710 |
Why?
|
Mitral Valve Insufficiency | 7 | 2022 | 1421 | 1.250 |
Why?
|
Heart Valve Prosthesis Implantation | 12 | 2023 | 1534 | 1.090 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2014 | 478 | 0.840 |
Why?
|
Aortic Valve | 12 | 2022 | 1921 | 0.740 |
Why?
|
Echocardiography, Three-Dimensional | 7 | 2016 | 591 | 0.740 |
Why?
|
Mitral Valve Prolapse | 1 | 2022 | 231 | 0.730 |
Why?
|
Mitral Valve Stenosis | 2 | 2018 | 376 | 0.630 |
Why?
|
Heart Valve Prosthesis | 6 | 2020 | 1488 | 0.610 |
Why?
|
Rheumatic Heart Disease | 1 | 2018 | 177 | 0.570 |
Why?
|
Stroke Volume | 13 | 2023 | 5008 | 0.490 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1072 | 0.470 |
Why?
|
Echocardiography | 18 | 2021 | 5103 | 0.440 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2023 | 2072 | 0.440 |
Why?
|
Vena Cava, Inferior | 2 | 2014 | 436 | 0.400 |
Why?
|
Papillary Muscles | 1 | 2012 | 203 | 0.400 |
Why?
|
Septal Occluder Device | 2 | 2016 | 128 | 0.390 |
Why?
|
Heart Atria | 2 | 2014 | 1356 | 0.380 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2011 | 125 | 0.360 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2023 | 349 | 0.340 |
Why?
|
Myocardial Contraction | 3 | 2012 | 1585 | 0.320 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2020 | 143 | 0.310 |
Why?
|
Ventricular Function, Left | 9 | 2023 | 3669 | 0.310 |
Why?
|
Foreign-Body Migration | 1 | 2009 | 221 | 0.300 |
Why?
|
Myocardial Ischemia | 4 | 2012 | 2148 | 0.300 |
Why?
|
Abnormalities, Multiple | 1 | 2014 | 1416 | 0.290 |
Why?
|
Echocardiography, Transesophageal | 3 | 2016 | 1132 | 0.280 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15538 | 0.260 |
Why?
|
Chest Pain | 1 | 2011 | 1114 | 0.240 |
Why?
|
Bioprosthesis | 1 | 2009 | 596 | 0.240 |
Why?
|
Tricuspid Valve | 3 | 2023 | 403 | 0.240 |
Why?
|
Patient Care Team | 1 | 2015 | 2529 | 0.230 |
Why?
|
Tachycardia, Ventricular | 1 | 2011 | 1273 | 0.220 |
Why?
|
Ventricular Remodeling | 3 | 2015 | 1224 | 0.220 |
Why?
|
Aged, 80 and over | 22 | 2022 | 57768 | 0.210 |
Why?
|
Anthracyclines | 3 | 2015 | 288 | 0.210 |
Why?
|
Heart Ventricles | 6 | 2019 | 3820 | 0.200 |
Why?
|
Mitral Valve | 3 | 2021 | 1490 | 0.190 |
Why?
|
Troponin I | 3 | 2015 | 619 | 0.190 |
Why?
|
Coronary Artery Disease | 4 | 2015 | 6489 | 0.180 |
Why?
|
Heart Diseases | 5 | 2016 | 2790 | 0.180 |
Why?
|
Anemia, Hemolytic | 1 | 2020 | 168 | 0.180 |
Why?
|
Atrial Fibrillation | 2 | 2015 | 5034 | 0.170 |
Why?
|
Hematuria | 1 | 2020 | 235 | 0.170 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.170 |
Why?
|
Echocardiography, Doppler, Color | 4 | 2016 | 364 | 0.150 |
Why?
|
Neovascularization, Physiologic | 5 | 2008 | 1351 | 0.150 |
Why?
|
Taxoids | 3 | 2015 | 665 | 0.140 |
Why?
|
Heart Failure | 6 | 2023 | 10905 | 0.140 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2008 | 282 | 0.140 |
Why?
|
Humans | 62 | 2023 | 744220 | 0.140 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1971 | 0.140 |
Why?
|
Vascular Fistula | 1 | 2016 | 50 | 0.140 |
Why?
|
S-Adenosylhomocysteine | 1 | 2016 | 41 | 0.140 |
Why?
|
Treatment Outcome | 20 | 2023 | 63119 | 0.130 |
Why?
|
Cardiotoxins | 1 | 2015 | 41 | 0.130 |
Why?
|
Electric Impedance | 1 | 2019 | 729 | 0.130 |
Why?
|
Endothelial Growth Factors | 5 | 2000 | 694 | 0.130 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1206 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2013 | 859 | 0.130 |
Why?
|
Female | 39 | 2023 | 380197 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2018 | 403 | 0.120 |
Why?
|
Cardiac Volume | 1 | 2015 | 210 | 0.120 |
Why?
|
Recovery of Function | 3 | 2019 | 2925 | 0.120 |
Why?
|
Aged | 23 | 2023 | 163253 | 0.120 |
Why?
|
Lymphokines | 4 | 1997 | 949 | 0.120 |
Why?
|
Bundle-Branch Block | 1 | 2015 | 270 | 0.110 |
Why?
|
Ultrasonography, Interventional | 3 | 2011 | 1483 | 0.110 |
Why?
|
Diagnosis, Differential | 5 | 2020 | 12961 | 0.110 |
Why?
|
American Heart Association | 1 | 2017 | 1056 | 0.110 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2015 | 272 | 0.110 |
Why?
|
Survival Rate | 4 | 2021 | 12781 | 0.110 |
Why?
|
Calcinosis | 2 | 2014 | 1499 | 0.110 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15070 | 0.110 |
Why?
|
Aortic Diseases | 2 | 2016 | 742 | 0.110 |
Why?
|
Male | 35 | 2023 | 350027 | 0.110 |
Why?
|
Pacemaker, Artificial | 2 | 2015 | 818 | 0.110 |
Why?
|
Doxorubicin | 2 | 2015 | 2220 | 0.100 |
Why?
|
Losartan | 1 | 2013 | 299 | 0.100 |
Why?
|
Breast Neoplasms | 6 | 2019 | 20817 | 0.100 |
Why?
|
Time Factors | 11 | 2022 | 40063 | 0.100 |
Why?
|
Thoracic Surgery | 1 | 2017 | 719 | 0.100 |
Why?
|
Arteriosclerosis | 1 | 1995 | 1092 | 0.090 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 453 | 0.090 |
Why?
|
Peroxidase | 1 | 2013 | 611 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2021 | 15294 | 0.090 |
Why?
|
Foramen Ovale, Patent | 2 | 2011 | 223 | 0.090 |
Why?
|
Benzopyrans | 1 | 2009 | 66 | 0.090 |
Why?
|
Carboxylic Acids | 1 | 2009 | 99 | 0.090 |
Why?
|
Ergolines | 1 | 2009 | 61 | 0.090 |
Why?
|
Aortic Valve Insufficiency | 1 | 2014 | 579 | 0.090 |
Why?
|
Myocytes, Cardiac | 3 | 2009 | 1637 | 0.090 |
Why?
|
Registries | 3 | 2020 | 8090 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1536 | 0.080 |
Why?
|
Leukotriene B4 | 1 | 2009 | 294 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1995 | 1504 | 0.080 |
Why?
|
Electrocardiography | 2 | 2012 | 6442 | 0.080 |
Why?
|
Guanylate Cyclase | 1 | 2009 | 201 | 0.080 |
Why?
|
Hyperprolactinemia | 1 | 2009 | 129 | 0.080 |
Why?
|
Endothelium, Vascular | 5 | 2005 | 4455 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3469 | 0.080 |
Why?
|
Myocardium | 2 | 2013 | 4776 | 0.080 |
Why?
|
Anesthesiology | 1 | 2017 | 1049 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2013 | 11493 | 0.070 |
Why?
|
Metabolomics | 1 | 2016 | 1483 | 0.070 |
Why?
|
Heart Valves | 1 | 2009 | 291 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2017 | 6535 | 0.070 |
Why?
|
Cardiology | 1 | 2017 | 1668 | 0.070 |
Why?
|
Heart | 2 | 2020 | 4465 | 0.070 |
Why?
|
Hospital Mortality | 5 | 2020 | 5316 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 1240 | 0.070 |
Why?
|
Societies, Medical | 1 | 2017 | 3741 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3114 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11728 | 0.070 |
Why?
|
Nitric Oxide | 3 | 2009 | 2131 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2007 | 534 | 0.060 |
Why?
|
Middle Aged | 19 | 2021 | 213367 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2013 | 1265 | 0.060 |
Why?
|
Phenotype | 1 | 2022 | 16365 | 0.060 |
Why?
|
Endocarditis | 1 | 2009 | 350 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 871 | 0.060 |
Why?
|
Risk Assessment | 5 | 2019 | 23337 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2023 | 77426 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2009 | 688 | 0.060 |
Why?
|
Dyspnea | 1 | 2011 | 1303 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3508 | 0.060 |
Why?
|
Coronary Vessels | 2 | 2008 | 3107 | 0.060 |
Why?
|
Propensity Score | 2 | 2022 | 1781 | 0.060 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13668 | 0.060 |
Why?
|
North America | 2 | 2019 | 1250 | 0.050 |
Why?
|
Apoptosis | 2 | 1998 | 9728 | 0.050 |
Why?
|
Hypertension | 3 | 2019 | 8480 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 916 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3509 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 5 | 2008 | 772 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1387 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2015 | 1573 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2009 | 1186 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8387 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4578 | 0.040 |
Why?
|
Ultrasonography | 2 | 2009 | 5982 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12244 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2020 | 440 | 0.040 |
Why?
|
Risk Factors | 8 | 2020 | 72280 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2586 | 0.040 |
Why?
|
Transfection | 2 | 1996 | 5892 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2013 | 3533 | 0.040 |
Why?
|
Urinalysis | 1 | 2020 | 369 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1998 | 52 | 0.040 |
Why?
|
Odds Ratio | 3 | 2016 | 9849 | 0.040 |
Why?
|
Hemodynamics | 2 | 2019 | 4199 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2020 | 415 | 0.040 |
Why?
|
Death | 1 | 2022 | 678 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 40559 | 0.040 |
Why?
|
Prospective Studies | 5 | 2023 | 53280 | 0.040 |
Why?
|
Linear Models | 2 | 2017 | 5953 | 0.040 |
Why?
|
DNA, Complementary | 2 | 1996 | 2050 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 1440 | 0.030 |
Why?
|
Quality of Life | 3 | 2023 | 12805 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1203 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2006 | 2267 | 0.030 |
Why?
|
Prevalence | 3 | 2020 | 15226 | 0.030 |
Why?
|
Collateral Circulation | 1 | 1996 | 287 | 0.030 |
Why?
|
Prognosis | 4 | 2019 | 29050 | 0.030 |
Why?
|
Tunica Intima | 1 | 1998 | 464 | 0.030 |
Why?
|
Atherectomy | 1 | 1995 | 47 | 0.030 |
Why?
|
Adult | 10 | 2019 | 214035 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9275 | 0.030 |
Why?
|
Angiography | 2 | 2017 | 1638 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13409 | 0.030 |
Why?
|
Acetylcholine | 1 | 1997 | 621 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12355 | 0.030 |
Why?
|
Catheterization | 2 | 1998 | 1469 | 0.030 |
Why?
|
Aortography | 1 | 2016 | 437 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 1995 | 285 | 0.030 |
Why?
|
Heart Transplantation | 1 | 2007 | 3123 | 0.030 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2015 | 176 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1841 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1265 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39045 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6308 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2170 | 0.030 |
Why?
|
Rabbits | 5 | 1998 | 4892 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 1998 | 934 | 0.030 |
Why?
|
Galectin 3 | 1 | 2015 | 227 | 0.030 |
Why?
|
Animals | 13 | 2020 | 168788 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2878 | 0.030 |
Why?
|
Femoral Artery | 1 | 1996 | 845 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 552 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 977 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2008 | 3506 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1995 | 2645 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 1995 | 1107 | 0.020 |
Why?
|
Troponin C | 1 | 2011 | 25 | 0.020 |
Why?
|
Atrial Septum | 1 | 2011 | 60 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2015 | 5096 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2017 | 964 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3339 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1995 | 970 | 0.020 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 388 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 642 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1655 | 0.020 |
Why?
|
Blood Vessels | 1 | 1995 | 1126 | 0.020 |
Why?
|
Fibroblast Growth Factors | 2 | 2008 | 879 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11368 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 107 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2204 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2009 | 199 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
Prolactinoma | 1 | 2009 | 113 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1995 | 1434 | 0.020 |
Why?
|
Ventricular Function | 1 | 2010 | 416 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2012 | 934 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15161 | 0.020 |
Why?
|
Regeneration | 1 | 1996 | 1485 | 0.020 |
Why?
|
Ischemia | 1 | 1996 | 1914 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
Prolactin | 1 | 2009 | 669 | 0.020 |
Why?
|
Endotoxins | 1 | 2009 | 527 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1442 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2029 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 607 | 0.020 |
Why?
|
Incidence | 2 | 2015 | 20945 | 0.020 |
Why?
|
Angiotensin II | 1 | 2009 | 881 | 0.020 |
Why?
|
Breast | 1 | 2015 | 1969 | 0.020 |
Why?
|
Growth Substances | 1 | 2008 | 783 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1866 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4929 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2110 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2009 | 19227 | 0.020 |
Why?
|
Stents | 1 | 1997 | 3280 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1995 | 2948 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2007 | 689 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18367 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3778 | 0.010 |
Why?
|
Recurrence | 1 | 1995 | 8343 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8663 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3701 | 0.010 |
Why?
|
Recombinant Proteins | 3 | 1997 | 6612 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9960 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2867 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 85759 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1995 | 4553 | 0.010 |
Why?
|
Genes, Reporter | 2 | 1996 | 1547 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10949 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3328 | 0.010 |
Why?
|
DNA Primers | 2 | 1996 | 2892 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9311 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20123 | 0.010 |
Why?
|
Aorta | 1 | 2009 | 2061 | 0.010 |
Why?
|
Plasmids | 2 | 1996 | 2307 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4935 | 0.010 |
Why?
|
United States | 2 | 2020 | 69867 | 0.010 |
Why?
|
Amyloidosis | 1 | 2007 | 795 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1677 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8321 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2009 | 1346 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14726 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12035 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 13990 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10387 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 56436 | 0.010 |
Why?
|
Blood Pressure | 2 | 2009 | 8551 | 0.010 |
Why?
|
Primary Prevention | 1 | 2006 | 1167 | 0.010 |
Why?
|
Polarography | 1 | 1997 | 10 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4419 | 0.010 |
Why?
|
Mice | 3 | 2009 | 81178 | 0.010 |
Why?
|
omega-N-Methylarginine | 1 | 1997 | 111 | 0.010 |
Why?
|
Calcium Chloride | 1 | 1997 | 77 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1996 | 6172 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19907 | 0.010 |
Why?
|
Lac Operon | 1 | 1996 | 238 | 0.010 |
Why?
|
Umbilical Veins | 1 | 1997 | 433 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3611 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5757 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1996 | 573 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1996 | 548 | 0.010 |
Why?
|
Base Sequence | 2 | 1996 | 12801 | 0.010 |
Why?
|
Endothelium | 1 | 1998 | 778 | 0.010 |
Why?
|
Sepsis | 1 | 2009 | 2593 | 0.010 |
Why?
|
Hindlimb | 1 | 1996 | 505 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4151 | 0.010 |
Why?
|
Graft Rejection | 1 | 2007 | 4399 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9735 | 0.010 |
Why?
|
Gene Expression | 2 | 1996 | 7799 | 0.010 |
Why?
|
Arginine | 1 | 1997 | 944 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1996 | 1525 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13280 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10250 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 1996 | 653 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1997 | 793 | 0.010 |
Why?
|
Arteries | 1 | 1997 | 1119 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 25618 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 21752 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21824 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1997 | 1082 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18027 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35423 | 0.010 |
Why?
|
Kinetics | 1 | 1997 | 6474 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1997 | 1912 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1997 | 5076 | 0.000 |
Why?
|
Child | 1 | 2011 | 77679 | 0.000 |
Why?
|
Thrombosis | 1 | 1997 | 2968 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1996 | 7723 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1996 | 13036 | 0.000 |
Why?
|
Glycogenolysis | 1 | 1958 | 6 | 0.000 |
Why?
|
Glycogen | 1 | 1958 | 260 | 0.000 |
Why?
|
Glucagon | 1 | 1958 | 533 | 0.000 |
Why?
|
Muscles | 1 | 1958 | 1622 | 0.000 |
Why?
|
Insulin | 1 | 1958 | 6583 | 0.000 |
Why?
|
Liver | 1 | 1958 | 7472 | 0.000 |
Why?
|
Diet | 1 | 1958 | 7937 | 0.000 |
Why?
|
Rats | 1 | 1958 | 24273 | 0.000 |
Why?
|